5,6-dihydroxyindole has been researched along with Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, FE; Barnham, KJ; Cappai, R; Gras, SL; Hill, AF; Kenche, VB; Leong, SL; Pham, CL | 1 |
| Charkoudian, LK; Franz, KJ | 1 |
| Arcadi, A; Bonfigli, A; Botti, D; Miranda, M; Ventura, T | 1 |
3 other study(ies) available for 5,6-dihydroxyindole and Parkinson Disease
| Article | Year |
|---|---|
Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner.
Topics: alpha-Synuclein; Antioxidants; Buffers; Dopamine; Humans; Hydrogen-Ion Concentration; Indoles; Molecular Structure; Oxidation-Reduction; Parkinson Disease; Protein Folding; Protein Structure, Secondary; Salts; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2009 |
Fe(III)-coordination properties of neuromelanin components: 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid.
Topics: Dopamine; Humans; Hydrogen-Ion Concentration; Indoles; Iron; Melanins; Neurodegenerative Diseases; Oxygen; Parkinson Disease; Spectrum Analysis; Titrimetry | 2006 |
Tyrosinase-like activity in normal human substantia nigra.
Topics: Aged; Brain Chemistry; Catechol Oxidase; Child; Dihydroxyphenylalanine; Dopamine; Electrophoresis, Polyacrylamide Gel; Humans; Indoles; Male; Middle Aged; Monophenol Monooxygenase; Parkinson Disease; Phenylthiourea; Substantia Nigra | 1984 |